Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.776,94
0,58%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni Regno Unito LSE Evgen Pharma Plc (EVG) Evgen Pharma Plc (EVG) Notizie

Evgen Pharma Plc

EVG
0,80
0,00 (0,00%)
26 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
25/4/202421:57ALNCNewsTRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast..
25/4/202416:46LSEG_RNSEvgen Pharma PLC Change of Name
22/4/202411:11LSEG_RNSEvgen Pharma PLC Holding(s) in Company
11/4/202416:04LSEG_RNSEvgen Pharma PLC Holding(s) in Company
09/4/202408:00LSEG_RNSEvgen Pharma PLC Holding(s) in Company
08/4/202417:03LSEG_RNSEvgen Pharma PLC Holding(s) in Company
05/4/202416:39LSEG_RNSEvgen Pharma PLC Director/PDMR Shareholding
05/4/202415:40LSEG_RNSEvgen Pharma PLC Holding(s) in Company
04/4/202418:24ALNCNewsTRADING UPDATES: Northcoders launches bootcamp; Schroder..
04/4/202414:59LSEG_RNSEvgen Pharma PLC Result of General Meeting
04/4/202408:00LSEG_RNSEvgen Pharma PLC Result of Retail Offer
19/3/202420:47ALNCNewsEARNINGS AND TRADING: Ten Lifestyle sees profit up but sales..
19/3/202418:03LSEG_RNSEvgen Pharma PLC Retail Offer
19/3/202418:00LSEG_RNSEvgen Pharma PLC Acquisition, Fundraising and Change of Name
27/2/202416:59ALNCNewsEvgen Pharma finds evidence of SFX-01 activity in colon..
27/2/202408:00LSEG_NONEvgen Pharma PLC SFX-01 positive update in bowel cancer..
19/2/202412:45ALNCNewsEvgen Pharma shares up on studies into SFX-01 product..
19/2/202412:22LSEG_NONEvgen Pharma PLC Positive update on SFX-01 in vitro GBM..
09/2/202419:53ALNCNewsTRADING UPDATES: Apax opts against lifting offer; DCI enters..
09/2/202412:01LSEG_RNSEvgen Pharma PLC Notice of Dispute lodged with Stalicla SA
16/1/202419:59ALNCNewsIN BRIEF: Evgen partner raises USD17.4 million to support..
16/1/202416:07RNSNONEvgen Pharma PLC Series B Fund Raise by partner, Stalicla SA
29/12/202312:29UKREGEvgen Pharma PLC Holding(s) in Company
22/12/202319:06ALNCNewsIN BRIEF: Evgen appoints Toni Hanninen as permanent CFO
22/12/202308:00UKREGEvgen Pharma PLC Directorate Changes
13/11/202308:00RNSNONEvgen Pharma PLC Upcoming conferences
31/10/202315:38ALNCNewsTRADING UPDATES: Acuity RM wins contract; Georgia Capital..
31/10/202308:00UKREGEvgen Pharma PLC Half-year Report
26/10/202308:00RNSNONEvgen Pharma PLC Erasmus Medical Center begins glioblastoma..
19/10/202320:39ALNCNewsIN BRIEF: Evgen showcases importance of new enteric-coated..
19/10/202315:26RNSNONEvgen Pharma PLC Authored Article Publication
05/9/202315:22ALNCNewsEvgen Pharma hires interim CFO from Faron, chair to retire..
05/9/202308:00UKREGEvgen Pharma PLC Directorate Changes
15/8/202311:01ALNCNewsEvgen Pharma says trial shows new SFX-01 drug formulation is..
15/8/202308:00UKREGEvgen Pharma PLC Final Report from Phase 1b PK/PD study
03/8/202313:38UKREGEvgen Pharma PLC Rule 17 Disclosure
02/8/202311:28ALNCNewsIN BRIEF: Evgen Pharma shares drop on ending of license..
02/8/202308:00UKREGEvgen Pharma PLC Return of rights to Sulforadex from..
21/7/202313:03UKREGEvgen Pharma PLC Result of AGM
27/6/202311:01ALNCNewsEvgen Pharma's SFX-01 has positive effects for treating a..
27/6/202308:00RNSNONEvgen Pharma PLC SFX-01 radiosensitisation effect confirmed..
20/6/202314:59UKREGEvgen Pharma PLC Notice of AGM & Posting of Annual Report
19/6/202311:05ALNCNewsEvgen collaborator receives grant from KWF Dutch Cancer..
19/6/202308:00UKREGEvgen Pharma PLC Grant Success for Glioblastoma studies
07/6/202312:41ALNCNewsEvgen Pharma confident amid Stalicla deal; CFO Moulson to..
07/6/202308:00UKREGEvgen Pharma PLC Final Results
26/5/202312:00UKREGEvgen Pharma PLC Notice of Results
Apertura: Min: Max:
Chiusura: 0,80

La tua Cronologia

LSE
EVG
Evgen Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network